XOMA logo

XOMA

XOMA Royalty Corporation

$34.58
$0.00(0.00%)
49
Overall
50
Value
63
Tech
34
Quality
How is this score calculated?
Market Cap
$431.53M
Volume
213.28K
52W Range
$18.35 - $39.92
Target Price
$65.75

Company Overview

Mkt Cap$431.53MPrice$34.58
Volume213.28KChange+0.00%
P/E Ratio-31.2Open$33.80
Revenue$6.7MPrev Close$34.58
Net Income$-13.8M52W Range$18.35 - $39.92
Div YieldN/ATarget$65.75
Overall49Value50
Quality34Technical63

No chart data available

About XOMA Royalty Corporation

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Sector: Healthcare
Industry: Biotechnology

Latest News

XOMA Royalty Corporation (XOMA) Gets a Buy from H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on XOMA Royalty Corporation today and set a price target of $97.00. Pantginis cove...

TipRanks Auto-Generated Intelligence Newsdesk19 days ago
ABCD
1SymbolPriceChangeVol
2XOMA$34.580%213.28K
3
4
5
6

Get XOMA Royalty Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.